item management s discussion and analysis of financial condition and results of operations general since inception  the company has been engaged  and for the foreseeable future expects to continue to be engaged  exclusively in the research and development and commercialization of its oled technology for use in flat panel displays and other applications 
to date  the company has generated minimal revenues and does not expect to generate any meaningful revenues for the foreseeable future and until such time  if ever  that it successfully demonstrates that its oled technology is commercially viable for one or more flat panel display and other applications and enters into license agreements  joint ventures or strategic alliances with third parties with respect to the technology 
the company has incurred significant losses since its inception  resulting in an accumulated deficit of  at december  results of operations year ended december  compared to year ended december  the company had a net loss of  or 
per share for the year ended december  compared to a net loss of  or 
per share for the year ended december  the increase in net loss was primarily attributable to the increase in research and development expenses and to an increase in general and administrative expenses  as described below 
research and development expenses were  for the year ended december  compared to  for the year ended december  for the year ended december   research and development expenses consisted of i payments in the amount of  to princeton university under the sponsored research agreement  ii payments in the amount of  for patent applications  prosecution and other intellectual property rights  iii costs incurred in the amount of  for the development and construction of and operations in the company s new facility and iv costs in the amount of  for the expansion and further development of the company s research and development team 
research and development expenses for the same period in consisted of i payments in the amount of  to princeton university under the sponsored research agreement  ii payments in the amount of  for patent applications  prosecution and other intellectual property rights  and iii costs in the amount of  associated with the company s development team located at princeton 
general and administrative expenses were  for the year ended december  compared to  for the year ended december  the increase in general and administrative expenses is due to stock issued as a bonus to two executive employees  resulting in a compensation charge of  in the company earned  from contract revenue in compared to  in the revenue was derived primarily from the continuation of a subcontract with princeton university  pursuant to a three year  million dollar contract princeton university received from the defense advanced research projects administration 
also  the company received an initial payment from the national science foundation  as a result of a phase ii grant 
year ended december  compared to year ended december  the company had a net loss of  or 
per share for the year ended december  compared to a net loss of  or 
per share for the year ended december  the decrease in the net loss was primarily attributable to the decrease in research and development expenses  which in included a non cash expense related to the value of common stock and warrants issued to princeton university and usc in the amount of  or 
per share 
the company earned  from contract research revenue in compared to  in the revenue was derived primarily from a subcontract with princeton university pursuant to a year  million contract princeton university received from the defense advanced research projects administration  a national science foundation grant and a grant from the new jersey commission on science and technology 
research and development expenses were  for the year ended december  compared to  for the year ended december  for the year ended december   research and development expenses consisted of i payments in the amount of  to princeton university under the sponsored research agreement  ii payments in the amount of  for patent applications  prosecution and other intellectual property rights  and iii costs in the amount of  associated with the company s development team located at princeton 
research and development expenses for the same period in consisted of i the issuance of common stock and warrants in connection with the company s sponsored research agreement  which resulted in a non cash charge of  ii payments in the amount of  to princeton university under the sponsored research agreement  and iii payments in the amount of  for patent applications  prosecution  and other intellectual property rights expenses 
liquidity and capital resources as of december   the company had cash and cash equivalents of  and short term investments of  compared to cash and cash equivalents of  and short term investments of  at december  in may  the company completed a private placement for  shares of the company s common stock at a price of for a unit consisting of one share of common stock and a warrant to purchase one share of the company s common stock at an exercise price ranging from 
the completion of the private placement resulted in proceeds of  net of costs associated with the completion of the private placement  in the amount of  also  during  warrants and options to purchase  shares of the company s common stock were exercised  resulting in cash proceeds of  during  private placement warrants to purchase  shares of the company s common stock were exercised  resulting in net cash proceeds of  to the company 
on april   the company completed a public offering of  shares of common stock at a price of per share and redeemable warrants to purchase  shares of common stock at an exercise price of per share  at a price of 
per warrant 
the company received net cash proceeds of  from the public offering excluding  representing a portion of the offering expenses previously charged to general and administrative expenses 
in  the company completed the construction of its new facility in ewing  new jersey 
costs incurred and paid in relating to the construction and purchase of equipment for the new facility amounted to  net working capital increased to  at december  from working capital of  at december   due primarily to the proceeds received in connection with the private placement and exercise of warrants and options during the company s net cash used in operating activities was   and  in  and respectively 
non cash expenses related to the issuance of common stock  warrants and options were   and  in  and respectively 
as of march  the company has obtained additional cash in the amount of  from the exercise of  warrants and options to purchase common stock 
the company anticipates  based on management s internal forecasts and assumptions relating to its operations including assumptions regarding working capital requirements of the company  the progress of research and development  the availability and amount of other sources of funding available to princeton university for research relating to the oled technology and the timing and costs associated with the preparation  filing and prosecution of patent applications and the enforcement of intellectual property rights that it has sufficient cash to meet its obligations for the sponsored research agreement requires the company to pay up to million to princeton university from july through july  which period is subject to extension 
the remaining obligation of the company under that agreement is  the company expects funding under this agreement in to be less than million maximum per the agreement 
substantial additional funds will be required for the research  development and commercialization of oled technology  obtaining and maintaining intellectual property rights  working capital and other purposes  the timing and amount of which is difficult to ascertain 
there can be no assurance that additional funds will be available when needed  or if available  on commercially reasonable terms 
item a 
quantitative and qualitative disclosure about market risk the company does not utilize financial instruments for trading purposes and holds no derivative financial instruments which could expose the company to significant market risk 
the company s primary market risk exposure with regard to financial instruments is to changes in interest rates 

